Search

Industry Expertise Evonik to Host Webinar Series on Advanced Drug Delivery

| Editor: Ahlam Rais

Evonik will be conducting the free weekly webinar series every Tuesday from October 6 – December 8, 2020. Each session will focus on key formulation, process and production challenges for complex oral and parenteral drug products.

Related Company

More than a dozen technical experts from Evonik, as well as other industry partners, will share their knowledge and be available to answer questions.
More than a dozen technical experts from Evonik, as well as other industry partners, will share their knowledge and be available to answer questions.
(Source: Deposit Photos)

Germany – Evonik invites pharmaceutical and biotechnology professionals to join a free ten-part webinar series on advanced drug delivery that will take place every Tuesday from October 6 – December 8, 2020.

As a global integrated CDMO leader for advanced drug delivery, Evonik will use the webinar series to review key formulation, process and manufacturing challenges for complex oral and parenteral drug products. More than a dozen technical experts from Evonik, as well as other industry partners, will share their knowledge and be available to answer questions. Each webinar will commence at 10:00 a.m. EDT / 4:00 p.m. CEST. Registration is via Evonik’s own platform On Care.

“Many of our pharmaceutical and biotechnology customers and other industry professionals from around the world are hungry to learn more about a series of key trending topics for advanced drug delivery,” said Paul Spencer, Head of Pharma Polymers and Services for Evonik’s Health Care business line. “With this ten-part webinar series, we look forward to sharing industry best practices and relevant case studies that can help them address specific formulation, process and manufacturing challenges for complex parenteral and oral drug products.”

The ten-part series will begin on Tuesday, October 6 with six weekly webinars dedicated to parenteral drug products. Topics will include polymeric microparticle and nanoparticle-based drug products, ocular drug delivery, parenteral excipients for extended release, and lipid nanoparticles for use with Covid-19 vaccines, nucleic acids and small molecules.

From November 3, four additional webinars will take place every Tuesday. The sessions will cover oral drug delivery topics including delayed release formulations, advanced colon targeting and reformulation strategies.

China’s Pharmaceutical Equipment Market - Current Status, Trends and Recommendations for Action

As China is emerging as one of the world’s fastest-growing markets for the consumption of pharmaceuticals, it also offers huge opportunities for the global equipment industry. This 40-page report aims to help you gain a better understanding of the current China's pharmaceutical market regarding a series of pharmaceutical industry related policies. Based on results of the survey among users in the pharmaceutical industry and the expert interviews, it will also provide you with a forecast for the industry and recommendations for your future operating and investment in China.

Evonik’s Health Care business line, which is part of the Nutrition and Care division of Evonik, is one of the world’s leading integrated CDMOs for complex oral and parenteral drug products that require advanced drug delivery solutions. It is also one of the world’s largest pharmaceutical suppliers of generic APIs, amino acids and cell culture ingredients, and among the top three global CMOs for APIs and intermediates.

To register for one or more webinars, click on the webinar title:

Tuesday, October 06 | 10 a.m. EDT / 4 p.m. CEST

Microparticle-based drug products: Best practices for processing and fill-finish

Tuesday, October 13 | 10 a.m. EDT / 4 p.m. CEST

Polymeric nanomedicines – Best practices to transition from an API into a final commercial product

Tuesday, October 20 | 10 a.m. EDT / 4 p.m. CEST

Ocular drug delivery – New and emerging material, formulation and processing opportunities

Tuesday, October 27 | 10 a.m. EDT / 3 p.m. CET

Lipid nanoparticle formulations for the delivery of nucleic acids

Tuesday, November 03 | 10 a.m. EDT / 4 p.m. CET

Developing extended release microparticles and nanoparticles with PLGA parenteral excipients

Tuesday, November 10 | 10 a.m. EDT / 4 p.m. CET

Specialised parenteral excipients for the delivery of complex parenteral drug products

Tuesday, November 17 | 10 a.m. EDT / 4 p.m. CET

Delayed and modified release oral formulations – A review of the latest innovations and trends

Tuesday, November 24 | 10 a.m. EDT / 4 p.m. CET

Advanced colonic targeting for oral drug products and other microbiome therapeutics

Tuesday, December 01| 10 a.m. EDT / 4 p.m. CET

A new product and service portfolio for enteric protection

Tuesday, December 08 | 10 a.m. EDT / 4 p.m. CET

Reformulation strategies for oral formulations

(ID:46864293)